Jhpiego   Report issue

Foundation Phase 4
Founded: Baltimore MD United States (1973)

Organization Overview

First Clinical Trial
2011
NCT01096134
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Jhpiego